What is the current Brera Holdings PLC share price?

The current share price of Brera Holdings PLC is US$ 25.20

What is the 1 year trading range for Brera Holdings PLC share price?

Brera Holdings PLC has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Brera【BREA】銘柄情報

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

期間 †

前日比

前日比 %

始値

高値

安値

平均出来高

VWAP

156

260

Statement From the Board of Brera Holdings Plc (“Solmate”)June 24, 2026 3:00 PM
Business Wire Solmate (Nasdaq: SLMT) IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE 1. KEY INFORMATION (a) Full name of discloser: Brera Holdings Plc (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Brera Holdings Plc (d) Is the discloser the offeror or the offeree? OFFEREE (e) Date position held: The latest practicable date prior to the disclosure 23 June 2026 (f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” NO 2. INTERESTS AND SHORT POSITIONS If there are interests and positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security. Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates (Note 1) Class of relevant security: (Note 2) Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled: Nil - Nil - (2) Cash-settled derivatives: Nil - Nil - (3) Stock-settled derivatives (including options) and agreements to purchase/ sell: Nil - Nil - Total: Nil - Nil - All interests and all short positions should be disclosed. Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8. 3. INTERESTS AND SHORT POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY MAKING THE DISCLOSURE Details of any interests and short positions (including directors’ and other employee options) of any person acting in concert with the party making the disclosure: Brera Holdings Plc Directors: The directors of Brera Holdings Plc detailed in the table below (together with their connected persons under Rule 3.3(b)(ii) of Part A of the Irish Takeover Rules) have the following interests in the relevant securities of Brera Holdings Plc. Class of Relevant Security Number of ordinary shares held at midnight on 23 June 2026 Percentage of issued share capital Total number of ordinary shares underlying unexercised warrants, restricted stock units (“RSUs”), and other subscription rights. Alyazi Saeed Ahmad Alkhattal Almheiri Class B Ordinary Shares 174,983 1.59% 87,777 Erez Simha Class B Ordinary Shares 0 0% 25,981 Keren Maimon Class B Ordinary Shares 1,336,330 12.12% 101,110 Ron Sade Class B Ordinary Shares 1,338,978 12.14% 104,888 Tariq Salem Ebraheem Alsaman Alnuaimi Class B Ordinary Shares 349,974 3.17% 171,110 Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8. 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” (b) Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. (c) Attachments Is a Supplemental Form 8 attached? YES/NO NO Date of disclosure: 24 June 2026 Contact name: Ron Sade Telephone number: +1 253-271-9108 Public disclosures under Rule 8.1 of the Rules must be made to a Regulatory Information Service. NOTES ON FORM 8.1(a) and (b) 1. See the definition of “interest in a relevant security” in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) of Part B of the Rules. 2. See the definition of “relevant securities” in Rule 2.1 of Part A of the Rules. 3. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted. For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel. References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022. FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Erez Simha (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree Brera Holdings Plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1) (e) Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure 23 June 2026 (f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” NO 2. INTERESTS AND SHORT POSITIONS If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security. Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) (Note 2) Class of relevant security
(Note 3) Class B Ordinary Shares with nominal value $0.50 each Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled 3,248 0.29% (2) Cash-settled derivatives (3) Stock-settled derivatives (including options) and agreements to purchase/ sell 22,733 0.21% Total 25,981 0.24% All interests and all short positions should be disclosed. Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8. 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4) Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant
security Purchase/sale Number of
securities Price per unit
(Note 5) N/A (b) Cash-settled derivative transactions Class of
relevant
security Product
description
e.g. CFD Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position Number of
reference
securities
(Note 6) Price
per unit
(Note 5) N/A (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of
relevant
security Product
description e.g. call
option Writing, purchasing, selling, varying
etc. Number
of
securities
to which
option
relates
(Note 6) Exercise
price per
unit Type
e.g.
American,
European
etc. Expiry
date Option
money
paid/
received per unit N/A (ii) Exercise Class of
relevant
security Product
description
e.g. call
option Exercising/
exercised
against Number of
securities Exercise
price per
unit
(Note 5) N/A (d) Other dealings (including transactions in respect of new securities) (Note 3) Class of
relevant
security Nature of dealing
e.g. subscription,
conversion, exercise Details Price per unit (if
applicable)
(Note 5) N/A 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer. Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” None (b) Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. None (c) Attachments Is a Supplemental Form 8 attached? YES Date of disclosure 24 June 2026 Contact name Erez Simha Telephone number +1 253-271-9108 Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service. NOTES ON FORM 8.3 1. See the definition of “connected fund manager” in Rule 2.2 of Part A of the Rules. 2. See the definition of “interest in a relevant security” in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules. 3. See the definition of “relevant securities” in Rule 2.1 of Part A of the Rules. 4. See the definition of “dealing” in Rule 2.1 of Part A of the Rules. 5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given. 6. See Rule 2.5(d) of Part A of the Rules. 7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted. For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel. References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022. SUPPLEMENTAL FORM 8 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND RIGHTS TO SUBSCRIBE FOR NEW SECURITIES 1. KEY INFORMATION Full name of person making
disclosure: Erez Simha Name of offeror/offeree in relation
to whose relevant securities the
disclosure relates: Brera Holdings Plc 2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS) Class of
relevant
security Product
description
e.g. call
option Written or
purchased Number of
securities to
which option
or derivative
relates Exercise
price
per unit Type
e.g.
American,
European
etc. Expiry
date 3. AGREEMENTS TO PURCHASE OR SELL Full details should be given so that the nature of the interest or position can be fully understood: 4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS) Class of relevant security in relation to which subscription right exists: Class B Ordinary Shares with nominal value $0.50 each Details, including nature of the rights concerned and relevant percentages: Restricted Stock Units (“RSUs”)1 Grant Date       Number of shares     Exercise Price     Expiry Date 3 April 2026      22,733                      $0.00                  None 1RSUs Vesting Schedule 1. 25,981 RSUs were granted on the grant date, and the RSUs vest in substantially equal quarterly installments over a two-year period commencing from the date of the grant. 2. To date, 3,248 units from the original grant of RSUs have vested, leaving 22,733 granted but unvested. 3. When all remaining RSUs vest, it will result in an increased interest of 0.21%. It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives. The currency of all prices and other monetary amounts should be stated. For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel. References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022. FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Alyazi Saeed Ahmad Alkhattal Almheiri (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree Brera Holdings Plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1) (e) Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure 23 June 2026 (f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” NO 2. INTERESTS AND SHORT POSITIONS If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security. Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) (Note 2) Class of relevant security
(Note 3) Class B Ordinary Shares with nominal value $0.50 each Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled 176,650 1.60% (2) Cash-settled derivatives (3) Stock-settled derivatives (including options) and agreements to purchase/ sell 86,110 0.78% Total 262,760 2.38% All interests and all short positions should be disclosed. Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8. 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4) Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant
security Purchase/sale Number of
securities Price per unit
(Note 5) N/A (b) Cash-settled derivative transactions Class of
relevant
security Product
description
e.g. CFD Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position Number of
reference
securities
(Note 6) Price
per unit
(Note 5) N/A (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of
relevant
security Product
description e.g. call
option Writing, purchasing, selling, varying
etc. Number
of
securities
to which
option
relates
(Note 6) Exercise
price per
unit Type
e.g.
American,
European
etc. Expiry
date Option
money
paid/
received per unit N/A (ii) Exercise Class of
relevant
security Product
description
e.g. call
option Exercising/
exercised
against Number of
securities Exercise
price per
unit
(Note 5) N/A (d) Other dealings (including transactions in respect of new securities) (Note 3) Class of
relevant
security Nature of dealing
e.g. subscription,
conversion, exercise Details Price per unit (if
applicable)
(Note 5) N/A 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer. Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” None (b) Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. None (c) Attachments Is a Supplemental Form 8 attached? YES Date of disclosure 24 June 2026 Contact name Alyazi Saeed Ahmad Alkhattal Almheiri Telephone number +1 253-271-9108 Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service. NOTES ON FORM 8.3 1. See the definition of “connected fund manager” in Rule 2.2 of Part A of the Rules. 2. See the definition of “interest in a relevant security” in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules. 3. See the definition of “relevant securities” in Rule 2.1 of Part A of the Rules. 4. See the definition of “dealing” in Rule 2.1 of Part A of the Rules. 5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given. 6. See Rule 2.5(d) of Part A of the Rules. 7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted. For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel. References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022. SUPPLEMENTAL FORM 8 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND RIGHTS TO SUBSCRIBE FOR NEW SECURITIES 1. KEY INFORMATION Full name of person making
disclosure: Alyazi Saeed Ahmad Alkhattal Almheiri Name of offeror/offeree in relation
to whose relevant securities the
disclosure relates: Brera Holdings Plc 2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS) Class of
relevant
security Product
description
e.g. call
option Written or
purchased Number of
securities to
which option
or derivative
relates Exercise
price
per unit Type
e.g.
American,
European
etc. Expiry
date 3. AGREEMENTS TO PURCHASE OR SELL Full details should be given so that the nature of the interest or position can be fully understood: 4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS) Class of relevant security in relation to which subscription right exists: Class B Ordinary Shares with nominal value $0.50 each Details, including nature of the rights concerned and relevant percentages: (a) Restricted Stock Units (“RSUs”)1 Grant Date                  Number of shares   Exercise Price     Expiry Date 23 September 2025     2,777                      $0.00                 23 October 2027 1RSUs Vesting Schedule 1. 4,444 RSUs were granted on the grant date, and the RSUs vest in substantially equal quarterly installments over a two-year period commencing from the date of the grant. 2. To date, 1,667 units from the original grant of RSUs have vested, leaving 2,777 granted but unvested. 3. When all remaining RSUs vest, it will result in an increased interest of 0.25%. (b) Outstanding warrants / rights to subscribe for Class B Ordinary shares Grant Date                    Number of shares      Exercise Price     Expiry Date 22 September 2025       55,555                        $0.50                 None 22 September 2025       27,778                        $67.50               22 September 2030 1. If exercised, this would result in an increased interest of 0.5%. It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives. The currency of all prices and other monetary amounts should be stated. For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel. References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022. FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Tariq Salem Ebraheem Alsaman Alnuaimi (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree Brera Holdings Plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1) (e) Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure 23 June 2026 (f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” NO 2. INTERESTS AND SHORT POSITIONS If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security. Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) (Note 2) Class of relevant security
(Note 3) Class B Ordinary Shares with nominal value $0.50 each Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled 351,641 3.19% (2) Cash-settled derivatives (3) Stock-settled derivatives (including options) and agreements to purchase/ sell 169,443 1.54% Total 521,084 4.72% All interests and all short positions should be disclosed. Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8. 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4) Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant
security Purchase/sale Number of
securities Price per unit
(Note 5) N/A (b) Cash-settled derivative transactions Class of
relevant
security Product
description
e.g. CFD Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position Number of
reference
securities
(Note 6) Price
per unit
(Note 5) N/A (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of
relevant
security Product
description e.g. call
option Writing, purchasing, selling, varying
etc. Number
of
securities
to which
option
relates
(Note 6) Exercise
price per
unit Type
e.g.
American,
European
etc. Expiry
date Option
money
paid/
received per unit N/A (ii) Exercise Class of
relevant
security Product
description
e.g. call
option Exercising/
exercised
against Number of
securities Exercise
price per
unit
(Note 5) N/A (d) Other dealings (including transactions in respect of new securities) (Note 3) Class of
relevant
security Nature of dealing
e.g. subscription,
conversion, exercise Details Price per unit (if
applicable)
(Note 5) N/A 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer. Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” None (b) Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. None (c) Attachments Is a Supplemental Form 8 attached? YES Date of disclosure 24 June 2026 Contact name Tariq Salem Ebraheem Alsaman Alnuaimi Telephone number +1 253-271-9108 Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service. NOTES ON FORM 8.3 1. See the definition of “connected fund manager” in Rule 2.2 of Part A of the Rules. 2. See the definition of “interest in a relevant security” in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules. 3. See the definition of “relevant securities” in Rule 2.1 of Part A of the Rules. 4. See the definition of “dealing” in Rule 2.1 of Part A of the Rules. 5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given. 6. See Rule 2.5(d) of Part A of the Rules. 7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted. For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel. References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022. SUPPLEMENTAL FORM 8 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND RIGHTS TO SUBSCRIBE FOR NEW SECURITIES 1. KEY INFORMATION Full name of person making
disclosure: Tariq Salem Ebraheem Alsaman Alnuaimi Name of offeror/offeree in relation
to whose relevant securities the
disclosure relates: Brera Holdings Plc 2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS) Class of
relevant
security Product
description
e.g. call
option Written or
purchased Number of
securities to
which option
or derivative
relates Exercise
price
per unit Type
e.g.
American,
European
etc. Expiry
date 3. AGREEMENTS TO PURCHASE OR SELL Full details should be given so that the nature of the interest or position can be fully understood: 4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS) Class of relevant security in relation to which subscription right exists: Class B Ordinary Shares with nominal value $0.50 each Details, including nature of the rights concerned and relevant percentages: (a) Restricted Stock Units (“RSUs”)1 Grant Date               Number of shares      Exercise Price      Expiry Date 23 September 2025 2,777                         $0.00                    23 October 2027 1RSUs Vesting Schedule 1. 4,444 RSUs were granted on the grant date, and the RSUs vest in substantially equal quarterly installments over a two-year period commencing from the date of the grant. 2. To date, 1,667 units from the original grant of RSUs have vested, leaving 2,777 granted but unvested. 3. When all remaining RSUs vest, it will result in an increased interest of 0.25%. (b) Outstanding warrants / rights to subscribe for Class B Ordinary shares Grant Date                  Number of shares        Exercise Price    Expiry Date 22 September 2025    111,111                        $0.50                 None 22 September 2025     55,555                         $67.50               22 September 2030 1. If exercised, this would result in an increased interest of 1.51%. It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives. The currency of all prices and other monetary amounts should be stated. For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel. References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022. FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Ron Sade (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree Brera Holdings Plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1) (e) Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure 23 June 2026 (f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” NO 2. INTERESTS AND SHORT POSITIONS If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security. Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) (Note 2) Class of relevant security
(Note 3) Class B Ordinary Shares with nominal value $0.50 each Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled 1,340,645 12.16% (2) Cash-settled derivatives (3) Stock-settled derivatives (including options) and agreements to purchase/ sell 103,221 0.94% Total 1,443,866 13.09% All interests and all short positions should be disclosed. Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8. 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4) Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant
security Purchase/sale Number of
securities Price per unit
(Note 5) N/A (b) Cash-settled derivative transactions Class of
relevant
security Product
description
e.g. CFD Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position Number of
reference
securities
(Note 6) Price
per unit
(Note 5) N/A (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of
relevant
security Product
description e.g. call
option Writing, purchasing, selling, varying
etc. Number
of
securities
to which
option
relates
(Note 6) Exercise
price per
unit Type
e.g.
American,
European
etc. Expiry
date Option
money
paid/
received per unit N/A (ii) Exercise Class of
relevant
security Product
description
e.g. call
option Exercising/
exercised
against Number of
securities Exercise
price per
unit
(Note 5) N/A (d) Other dealings (including transactions in respect of new securities) (Note 3) Class of
relevant
security Nature of dealing
e.g. subscription,
conversion, exercise Details Price per unit (if
applicable)
(Note 5) N/A 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer. Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” None (b) Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. None (c) Attachments Is a Supplemental Form 8 attached? YES Date of disclosure 24 June 2026 Contact name Ron Sade Telephone number +1 253-271-9108 Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service. NOTES ON FORM 8.3 1. See the definition of “connected fund manager” in Rule 2.2 of Part A of the Rules. 2. See the definition of “interest in a relevant security” in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules. 3. See the definition of “relevant securities” in Rule 2.1 of Part A of the Rules. 4. See the definition of “dealing” in Rule 2.1 of Part A of the Rules. 5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given. 6. See Rule 2.5(d) of Part A of the Rules. 7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted. For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel. References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022. SUPPLEMENTAL FORM 8 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND RIGHTS TO SUBSCRIBE FOR NEW SECURITIES 1. KEY INFORMATION Full name of person making
disclosure: Ron Sade Name of offeror/offeree in relation
to whose relevant securities the
disclosure relates: Brera Holdings Plc 2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS) Class of
relevant
security Product
description
e.g. call
option Written or
purchased Number of
securities to
which option
or derivative
relates Exercise
price
per unit Type
e.g.
American,
European
etc. Expiry
date 3. AGREEMENTS TO PURCHASE OR SELL Full details should be given so that the nature of the interest or position can be fully understood: 4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS) Class of relevant security in relation to which subscription right exists: Class B Ordinary Shares with nominal value $0.50 each Details, including nature of the rights concerned and relevant percentages: (a) Restricted Stock Units (“RSUs”)1 Grant Date                   Number of shares        Exercise Price        Expiry Date 23 September 2025     2,777                           $0.00                     23 October 2027 1RSUs Vesting Schedule 1. 4,444 RSUs were granted on the grant date, and the RSUs vest in substantially equal quarterly installments over a two-year period commencing from the date of the grant. 2. To date, 1,667 units from the original grant of RSUs have vested, leaving 2,777 granted but unvested. 3. When all remaining RSUs vest, it will result in an increased interest of 0.25%. (b) Outstanding warrants / rights to subscribe for Class B Ordinary shares Grant Date                  Number of shares        Exercise Price        Expiry Date 22 September 2025    55,555                         $0.50                      None 22 September 2025    27,778                         $67.50                    22 September 2030 23 September 2025    17,111                         $67.50                    23 September 2028 1. If exercised, this would result in an increased interest of 0.91%. It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives. The currency of all prices and other monetary amounts should be stated. For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel. References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022. FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Keren Kalima Maimon (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree Brera Holdings Plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1) (e) Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure 23 June 2026 (f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” NO 2. INTERESTS AND SHORT POSITIONS If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security. Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) (Note 2) Class of relevant security
(Note 3) Class B Ordinary Shares with nominal value $0.50 each Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled 1,337,997 12.13% (2) Cash-settled derivatives (3) Stock-settled derivatives (including options) and agreements to purchase/ sell 99,443 0.90% Total 1,437,440 13.03% All interests and all short positions should be disclosed. Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8. 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4) Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant
security Purchase/sale Number of
securities Price per unit
(Note 5) N/A (b) Cash-settled derivative transactions Class of
relevant
security Product
description
e.g. CFD Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position Number of
reference
securities
(Note 6) Price
per unit
(Note 5) N/A (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of
relevant
security Product
description e.g. call
option Writing, purchasing, selling, varying
etc. Number
of
securities
to which
option
relates
(Note 6) Exercise
price per
unit Type
e.g.
American,
European
etc. Expiry
date Option
money
paid/
received per unit N/A (ii) Exercise Class of
relevant
security Product
description
e.g. call
option Exercising/
exercised
against Number of
securities Exercise
price per
unit
(Note 5) N/A (d) Other dealings (including transactions in respect of new securities) (Note 3) Class of
relevant
security Nature of dealing
e.g. subscription,
conversion, exercise Details Price per unit (if
applicable)
(Note 5) N/A 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer. Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” None (b) Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. None (c) Attachments Is a Supplemental Form 8 attached? YES Date of disclosure 24 June 2026 Contact name Keren Kalima Maimon Telephone number +1 253-271-9108 Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service. NOTES ON FORM 8.3 1. See the definition of “connected fund manager” in Rule 2.2 of Part A of the Rules. 2. See the definition of “interest in a relevant security” in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules. 3. See the definition of “relevant securities” in Rule 2.1 of Part A of the Rules. 4. See the definition of “dealing” in Rule 2.1 of Part A of the Rules. 5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given. 6. See Rule 2.5(d) of Part A of the Rules. 7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted. For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel. References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022. SUPPLEMENTAL FORM 8 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND RIGHTS TO SUBSCRIBE FOR NEW SECURITIES 1. KEY INFORMATION Full name of person making
disclosure: Keren Kalima Maimon Name of offeror/offeree in relation
to whose relevant securities the
disclosure relates: Brera Holdings Plc 2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS) Class of
relevant
security Product
description
e.g. call
option Written or
purchased Number of
securities to
which option
or derivative
relates Exercise
price
per unit Type
e.g.
American,
European
etc. Expiry
date 3. AGREEMENTS TO PURCHASE OR SELL Full details should be given so that the nature of the interest or position can be fully understood: 4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS) Class of relevant security in relation to which subscription right exists: Class B Ordinary Shares with nominal value $0.50 each Details, including nature of the rights concerned and relevant percentages: (a) Restricted Stock Units (“RSUs”)1 Grant Date                 Number of shares        Exercise Price        Expiry Date 23 September 2025    2,777                          $0.00                     23 October 2027 1RSUs Vesting Schedule 1. 4,444 RSUs were granted on the grant date, and the RSUs vest in substantially equal quarterly installments over a two-year period commencing from the date of the grant. 2. To date, 1,667 units from the original grant of RSUs have vested, leaving 2,777 granted but unvested. 3. When all remaining RSUs vest, it will result in an increased interest of 0.25%. (b) Outstanding warrants / rights to subscribe for Class B Ordinary shares Grant Date                     Number of shares         Exercise Price        Expiry Date 22 September 2025        55,555                         $0.50                      None 22 September 2025        27,778                         $67.50                    22 September 2030 23 September 2025        13,333                         $67.50                    23 September 2028 1. If exercised, this would result in an increased interest of 0.88%. It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives. The currency of all prices and other monetary amounts should be stated. For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel. References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022. View source version on businesswire.com: https://www.businesswire.com/news/home/20260624511747/en/ Enquiries:
Solmate
Alex Corp
Wachsman
alex.corp@wachsman.com Original: Statement From the Board of Brera Holdings Plc (“Solmate”)

Statement From the Board of Brera Holdings Plc (“Solmate”)June 10, 2026 5:26 PM
Business Wire Announcement Regarding Number of Relevant Securities in Issue NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.12 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 (THE “IRISH TAKEOVER RULES”). Solmate (Nasdaq: SLMT) notes the announcement of Forward Industries, Inc on 9 June 2026 and confirms that, following careful consideration of the preliminary non-binding letter of intent received from Forward Industries, Inc in consultation with its advisers, the board of Solmate resolved to reject the non-binding proposal on 6 June 2026 as it does not consider the proposal to be in the best interest of the Company. For the purpose of Rule 2.12 of the Irish Takeover Rules, Solmate confirms that, as of the close of business on 9 June 2026, the issued share capital of Solmate was 11,009,294 Class B Ordinary shares with nominal value US$0.50 each (the “Class B Ordinary Shares”) and 20,000 Series A Preferred Shares with nominal value of US0.005 each. Solmate does not have any shares which are held as treasury shares. In addition, as of the close of business on 9 June 2026, there were outstanding warrants issued by Solmate to purchase 7,199,860 Class B Ordinary Shares, and 45,979 non-vested restricted share units granted by Solmate, each entitling the holder, subject to vesting, to one Class B Ordinary Share. The International Securities Identification Number for the Class B Ordinary Shares is IE0009876H30. Advisors
Paul Hastings LLP and Arthur Cox LLP are acting as legal counsel to Solmate. About Solmate
For information about Solmate, please visit www.solmate.com. Responsibility Statement
The directors of Solmate accept responsibility for the information contained in this announcement. To the best of their knowledge and belief (having taken all reasonable care to ensure such is the case), the information contained in this announcement is in accordance with the facts and does not omit anything likely to affect the import of such information. Disclosure Requirements of the Irish Takeover Rules
Under Rule 8.3(a) of the Irish Takeover Rules, any person who is “interested” (directly or indirectly) in 1% or more of any class of “relevant securities” of an offeree company or a securities exchange offeror (being any offeror other than an offeror which has announced that its offer is, or is likely to be, solely in cash) must make an “opening position disclosure” by no later than 3.30 pm (US Eastern Time) on the tenth “business day” following the commencement of the “offer period” and, if later, following the announcement in which any securities exchange offeror is first identified. An “opening position disclosure” must contain, among other things, the details specified in Rule 8.6(a) of the Irish Takeover Rules, including details of the person’s “interests” and “short positions” in any “relevant securities” of each of (i) the offeree company and (ii) any securities exchange offeror. Under Rule 8.3(b) of the Irish Takeover Rules, any person who is, or becomes, “interested” (directly or indirectly) in 1% or more of any class of “relevant securities” of an offeree company or a securities exchange offeror (being any offeror other than an offeror which has announced that its offer is, or is likely to be, solely in cash) must disclose all “dealings” in such “relevant securities” during the “offer period”. The disclosure of a “dealing” in “relevant securities” by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (US Eastern Time) on the “business day” following the date of the relevant “dealing”. A dealing disclosure must contain the details specified in Rule 8.6(b) of the Irish Takeover Rules, including details of the dealing concerned (and the prices paid or received) and of the person's “interests” and “short positions” in (including rights to subscribe for) any “relevant securities”. In addition, each of the offeree company and the offeror must make an “opening position disclosure” by no later than 12 noon (US Eastern Time) on the day falling 10 “business days” following the commencement of the “offer period” and must subsequently disclose details of any “dealings” by it or any person “acting in concert” with it in “relevant securities” of the offeree company or the securities exchange offeror (being any offeror other than an offeror which has announced that its offer is, or is likely to be, solely in cash) by no later than 12 noon (US Eastern Time) on the “business day” following the relevant “dealing”. All subsequent “dealings” in “relevant securities” of the offeree company or the securities exchange offeror by the offeror or the offeree company, or by any party acting in concert with any of them, must also be disclosed by no later than 12 noon (US Eastern Time) on the “business day” following the date of the relevant “dealing”. If two or more persons co-operate on the basis of an agreement, either express or tacit, either oral or written, to acquire an “interest” in “relevant securities” of the offeree company or the securities exchange offeror (being any offeror other than an offeror which has announced that its offer is, or is likely to be, solely in cash), they will be deemed to be a single person for the purpose of Rule 8.3(a) and (b) of the Irish Takeover Rules. A disclosure table, giving details of the companies in whose “relevant securities” opening position disclosures and dealing disclosures should be made, can be found on the Irish Takeover Panel’s website at www.irishtakeoverpanel.ie. “Interests in securities” arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an “interest” by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities. Terms in quotation marks in this section are defined in the Irish Takeover Rules, which can also be found on the Irish Takeover Panel’s website. If you are in any doubt as to whether or not you are required to disclose an “opening position” or “dealing” under Rule 8, please consult the Irish Takeover Panel’s website at www.irishtakeoverpanel.ie or contact the Irish Takeover Panel on telephone number +353 1 678 9020. Publication on Website In accordance with Rule 26.1 of the Irish Takeover Rules, a copy of this announcement will be available on Solmate’s website by no later than 12 noon (US Eastern Time) on the business day following publication of this announcement. The content of the website referred to in this announcement is not incorporated into, and does not form part of, this announcement. No Offer or Solicitation This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction, whether pursuant to this announcement or otherwise. The distribution of this announcement in jurisdictions outside Ireland or the United States may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction. Requesting Hard Copy Information Any Solmate shareholder may request a copy of this announcement in hard copy form by writing to the Company Secretary, Brera Holdings PLC, 5th Floor Rear, Connaught House, 1 Burlington Road, Dublin 4, Ireland. Any such requests must include the identity of the Solmate shareholder and any hard copy documents will be posted to the address of the Solmate shareholder provided in the request. Cautionary Disclosure Regarding Forward-Looking Statements This announcement includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “expect,” “intend,” “plan,” “anticipate,” “believe,” “will,” and similar expressions. These statements include, but are not limited to, statements regarding the Company’s business strategy, future growth, market opportunities and shareholder value creation. These forward-looking statements are based on current expectations, estimates, assumptions and projections and involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied by such statements. Additional information concerning these and other risks is contained in the Company’s filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements except as required by applicable law. Solmate’s forward-looking statements are based on estimates and assumptions that are made within the bounds of Solmate’s knowledge of Solmate’s business and operations and that Solmate considers reasonable. However, Solmate’s business and operations are subject to significant risks, and, as a result, there can be no assurance that actual results and the results of the company’s business and operations will not differ materially from the results contemplated in such forward-looking statements. Factors that could cause actual results to differ from expectations in Solmate’s forward-looking statements include the risks and uncertainties described under the heading “Risk Factors” in Solmate’s most recent Annual Report on Form 20-F and subsequent filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made and are not guarantees of future performance. Accordingly, you should not place undue reliance on forward-looking statements. Solmate does not undertake any obligation to publicly update or revise its forward-looking statements, except as required by law. View source version on businesswire.com: https://www.businesswire.com/news/home/20260610017124/en/ Enquiries:

Solmate
Alex Corp
Wachsman
alex.corp@wachsman.com Original: Statement From the Board of Brera Holdings Plc (“Solmate”)